Author:
Falk Delgado Anna,Van Westen Danielle,Nilsson Markus,Knutsson Linda,Sundgren Pia C.,Larsson Elna-Marie,Falk Delgado Alberto
Publisher
Springer Science and Business Media LLC
Subject
Radiology Nuclear Medicine and imaging
Reference150 articles.
1. Runge VM, Clanton JA, Price AC, Wehr CJ, Herzer WA, Partain CL et al (1985) The use of Gd DTPA as a perfusion agent and marker of blood-brain barrier disruption. Magn Reson Imaging. 3:43–55
2. EMA (2017) EMA’s final opinion confirms restrictions on use of linear gadolinium agents in body scans. Available via
www.ema.europa.eu/documents/press-release/emas-final-opinion-confirmsrestrictions-use-linear-gadolinium-agents-body-scans_en.pdf
. Accessed on 30 Nov 2018.
3. Wang Y, Alkasab TK, Narin O, Nazarian RM, Kaewlai R, Kay J et al (2011) Incidence of nephrogenic systemic fibrosis after adoption of restrictive gadolinium-based contrast agent guidelines. Radiology 260:105–111
4. Bennett CL, Qureshi ZP, Sartor AO, Norris LB, Murday A, Xirasagar S et al (2012) Gadolinium-induced nephrogenic systemic fibrosis: the rise and fall of an iatrogenic disease. Clin Kidney J 5:82–88
5. Gulani V, Calamante F, Shellock FG, Kanal E, Reeder SB (2017) Gadolinium deposition in the brain: summary of evidence and recommendations. Lancet Neurol. 16:564–570
Cited by
50 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献